Abstract: This paper uses the rollout of the first Community Health Centers (CHCs) to estimate the longterm health effects of increasing access to primary care. The results show that CHCs reduced age-adjusted mortality rates among those 50 and older by almost 2 percent within 10 years. The implied 6-to 8-percent decrease in one-year mortality risk among the treated amounts to 18 to 24 percent of the 1966 poor-nonpoor mortality gap for this age group. Large effects for those 65 and older suggest that increased access to primary care has long-term benefits, even for populations with near universal health insurance.
studies have considered their effects on health. Even taking for granted that CHCs increase service use, the program need not improve health or reduce health care costs if-as articulated by the program's early critics-its services are lower quality than those available from private and non-profit providers (covered by Medicare and Medicaid for many CHC patients). Moreover, if lower quality services gradually erode health, CHCs could ultimately raise health care costs. The efficacy of health care investments in CHCs, therefore, depends crucially on how they affect health-especially in the longer term.
This paper uses the rollout of the first CHCs from 1965 to 1974 to provide new evidence on their long-term health effects and, more generally, of increasing access to primary care. An important benefit of this historical vantage point is that we can evaluate the cumulative impact of primary care up to 15 years after local CHCs began, while using the "great administrative confusion" at the Office of Economic Opportunity (OEO) as our source of identification (Levine 1970) . We focus on the mortality of adults 50 and older for substantive and practical reasons.
Substantively, adults 50 and older account for an important and rising share of U.S. health care costs, and their health (and mortality) is sensitive to the provision of medical care.
3 A practical reason is that adults 50 and older comprise over 80 percent of deaths in the U.S. during our period of interest (which provides large sample sizes), and their mortality is consistently and precisely measured in every year at the county-level.
Our main results show that when communities received a CHC program predicts off-trend reductions in older-adult mortality which lasted over 15 years. One decade after CHCs began, age-adjusted, older-adult mortality rates remained almost 2 percent lower than pre-program levels, mostly due to decreases in deaths from cardiovascular-disease-related causes. These estimates are unchanged and often strengthened by including state-by-year fixed effects, countylevel federal per-capita medical spending, and linear county-level trends, as well as by reweighting the distribution of observed characteristics in untreated locations to resemble those in treated locations. Consistent with a causal interpretation of our estimates, a falsification test shows that CHCs had no impact on accident-related mortality. These results also stand contrary to an alternative explanation that the establishment of CHCs proxies for improvements in emergency care or the growth in local hospital capacity. The translation of our intention-to-treat effects into a treatment effects on the treated implies a 6-to 8-percent reduction in age-adjusted mortality among the 50-and-older poor-an effect equal to 18 to 24 percent of the 1966 poornonpoor mortality gap for the same age group.
Interestingly, the largest reductions in mortality were achieved among the Medicare eligible without an accompanying increase in Medicare spending. Our analysis of the restricted Survey of Health Services Utilization and Expenditures highlights two important reasons for this. As CHCs brought primary care to underserved areas, the share of older, poor adults reporting a "regular source of care" increased by over 20 percent. In addition, substantially discounted medications at
CHCs' in-house pharmacies (rarely covered by Medicaid or Medicare) reduced the share of the older poor with any prescription drug expenditures by almost 40 percent. These findings-and the likelihood that reductions in mortality understate the broader health benefits of CHCshighlight the value of interventions that increase access to primary care, even for populations with near universal health insurance coverage.
I. BACKGROUND AND EXPECTED EFFECTS OF COMMUNITY HEALTH CENTER PROGRAM A. Brief History of Community Health Centers
In his first State of the Union Address in January 1964, President Lyndon B. Johnson declared an "unconditional war on poverty." Central to his war was the 1964 Economic Opportunity Act (EOA) (P.L. 88-452, 78 Stat. 508), which aimed to "eliminate the paradox of poverty in the midst of plenty." The Office of Economic Opportunity (OEO) was created to administer the EOA initiatives and made direct grants to local organizations. 4 Initially, the OEO focused on programs to promote human capital and community development like Head Start and Job Corps. But OEO administrators soon discovered that health problems and access to care limited participation in their programs. In the 1950s and 1960s, few charity or reduced-cost providers existed in many parts of the U.S., especially rural areas. Even in cities, few office-based practitioners remained since private physicians followed the suburbanizing middle class (Sardell 1986: 45 And, even if an outpatient department existed locally, the "four-hour wait, multiple referrals, incredible discontinuity of care and various other indignities" (Knowles 1969: 178) certainly would have deterred many of the poor from seeking care there for non-emergencies.
To address the health needs of the poor, the OEO initiated the CHC program in 1965, which aimed to deliver affordable, comprehensive care to disadvantaged populations. 
B. What Did Neighborhood Health Centers Do and Whom Did They Serve?
Because OEO administrators believed that existing health services had failed to reach the poor, CHC grants were channeled to "alternative" delivery strategies. 5 The OEO model allowed any organization to apply and receive funding. Administrators initially lacked clear funding guidelines and report having received applications from "various and sundry groups" that often had little to do with the spirit of the legislation (Gillette 1996: 196 , quoting Theodore M. Berry, assistant director of the OEO). Finding proposals that fit the objectives of the CHC program was no small task. Awardees tended to be "one leading-edge, creative person who managed to get enough resources together…pulling them [others at the organization] kicking and screaming into something that they really didn't want to be in, but that had lots of dollars attached to it" (May et al. 1980: 587) . 
C. The Expected Effects of Community Health Centers on Older-Adult Mortality
The CHC program rolled out during a period of dramatic declines in U.S. mortality. Ageadjusted mortality rates for 50+ year olds fell from 3,292 deaths per 100,000 in 1960 to 2,372 deaths per 100,000 in 1988-a decline of almost 28 percent ( figure 1A ; see section II.A for details on variable construction and appendix A for cause coding). Figures 1B, 1C , and 1D show that longevity also increased, as age-specific mortality rates for ages 50-64, 65-79, and 80+ fell by 30, 28 and 25 percent, respectively, over the same period. Much of the decline in mortality rates was driven by the reduction in deaths from major cardiovascular causes (CVD), which includes both diseases of the heart as well as cerebrovascular causes like strokes (see appendix figure B1 for cause-specific trends). In 1960, CVD-related deaths accounted for over half of all deaths among those ages 50+, but CVD-related mortality had fallen by almost 50 percent by 1988. Deaths due to disease of the heart had fallen by 42 percent (676 deaths per 100,000) and other CVD-related causes by 60 percent (288 deaths per 100,000).
Important innovations in anti-hypertensive drugs, including diuretics and beta-blockers, affected these declines (Crimmins 1981: 244, Cutler and Kadiyala 2003 Over the same period, mortality due to infectious diseases, diabetes, and accidents also fell steadily. In contrast, cancer-related deaths increased. The causes of these increases in cancer and diabetes are not well understood but are often linked to worsening diet, increases in smoking, changes in cancer reporting, and reductions in heart disease and stroke, which were the main competing mortality risks.
CHCs potentially affected these mortality trends by reducing both the financial and "nonfinancial costs" of receiving primary care, including discounted appointments and drugs, reduced time costs, and reduced interpersonal barriers (community members were hired to do health education and outreach). A standard model of health care utilization predicts that CHCs' delivery of lower-cost care and prescription drugs should impact older adult mortality risk through two main channels. First, lower financial and non-financial costs should (weakly) increase the use of primary care on both the extensive and intensive margins. 8 This effect should be largest among those least able to afford (without insurance, for instance) or to travel to receive medical care.
Greater use of primary care should reduce mortality by increasing early detection of health problems, especially asymptomatic but lethal conditions like hypertension. Complementing detection, drug coverage may have been particularly important, because Medicare did not reimburse these costs (Finkelstein and McKnight 2008) and Medicaid rarely covered drugs (Davis and Schoen 1977: 55) . 9 Reduced-cost drugs (like anti-hypertensive medications) should 7 The first VACG study randomly assigned 73 middle aged men with moderate hypertension (diastolic blood pressure between 115 and 129 mm Hg) to a treatment group that received three hypertension medications; 73 men were also assigned to a control group that received placebo medications. Patients were followed for 4 and 24 months. The control group experienced 27 morbid events and 4 deaths while the treatment group experienced only two morbid events and zero deaths (VACG 1967) . Researchers terminated the study for moderate hypertensives after six months due to the large observed treatment effects. The second VACG study used the same methodology but focused on 380 men with low hypertension (diastolic blood pressure between 90 and 114 mm Hg). The study followed patients for an average of 3.3 years during which time 21 control patients and 10 treatment patients died. In addition, more than twice as many control patients had assessable morbid events (VACG 1970) . 8 Okada and Wan (1980) provide evidence for this using the OEO's before-and-after survey of CHC catchment areas in five cities (Boston, Charleston, South Carolina, Atlanta, Kansas City, and Palo Alto). In their comparison of average annual visits to physicians before and after the introduction of CHCs, they show that the 65 and older group is the only group in which average annual physicians' visits had increased by more in CHC catchment areas than in the U.S. overall between 1969 and 1975. According to their table 5 (524), the unadjusted difference in visits for those 65 and older in areas with CHCs had fallen by 66 percent over this period and remained constant for those 45 to 64, whereas the unadjusted difference had grown considerably for those under 44. 9 The incidence of cardiovascular-related mortality was over 47 percent higher among whites with less than 8 years of schooling relative to whites with at least one year of college (Kitagawa and Hauser 1973: 76) . This is also consistent with the RAND Health (weakly) increase compliance with recommended treatments and also reduce mortality risk.
Finally, CHCs may have reduced the cost of learning about Medicare and Medicaid, which should also decrease mortality through better treatment in hospitals (Chay et al. 2011) .
A second channel is that CHCs may have diverted care from other sources. The effect of this diversion on mortality, however, depends upon the relative quality of CHC care. Many accounts suggest that CHCs provided higher quality care than did hospital out-patient departments, but for many patients the relevant alternative was care from private providers that were covered under Medicaid or Medicare. If CHCs provided lower quality care than alternatives, then the diversion of care would tend to increase shorter-and longer-term mortality risk. On the other hand, if
CHCs provided relatively higher quality care than these private alternatives, then the diversion of care to CHCs would reduce mortality risk. These opposing effects make the overall effects of CHCs on mortality theoretically ambiguous.
Further complicating these predictions is that greater use of primary care and the diversion of care could have important, community-level externalities. Treating infectious disease, for instance, may reduce mortality among CHC non-patients. Health information and education has the same potential for community-level spillovers if, for instance, CHC patients share this information with their spouses and neighbors who are not CHC patients. Finally, the diversion of less-urgent cases from emergency departments may have improved treatment of urgent cases, which could also decrease community-level mortality risk among CHC non-patients.
In summary, both the sign and the magnitude of CHCs' effects on mortality are theoretically ambiguous. After reviewing previous studies, this paper uses a new reduced-form empirical strategy to quantify the program's effects on mortality through the combination of these channels.
D. Previous Studies of the Effects of Community Health Centers
Although a large body of research has examined CHCs, these studies' reliance on empirical methodologies with limited internal and external validity limits causal inferences about CHCs' health effects. 10 The literature's use of cross-sectional variation is tenuous, because communities Experiment's finding that free care significantly improved the control of hypertension and reduced mortality among hypertensives (Newhouse et al. 1993) . 10 Much of the literature examines a single CHC or a narrow geographic area and, therefore, cannot separate the effects of CHCs from changes in local policies or circumstances. For examples of case studies, see Bellin et al. (1969) and Moore et al. (1972) (Okada and Wan 1980, Freeman et al. 1982) . Focusing on later periods, Deprez et al. (1987) To avoid both sources of endogeneity, this paper's empirical strategy relies only upon variation in the date CHCs were established.
In addition to these methodological shortcomings, another limitation of the literature is that few studies consider CHCs' health effects. The handful that do consider them focus on infants (Chabot 1971 , Goldman and Grossman 1988 , Shi et al. 2004a , and Shi et al. 2004b Hedberg et al. 1996 and Falik et al. 2001 for preventative care). None, to our knowledge, has considered CHCs' cumulative or longer-term impacts on older-adult mortality, which is the focus of this study.
II. DATA AND EMPIRICAL STRATEGY: USING THE ROLLOUT OF COMMUNITY HEALTH CENTERS TO IDENTIFY THEIR MORTALITY EFFECTS
Newly compiled data on when and where CHCs were established facilitate this paper's empirical strategy. The following sections describe our data on CHCs and county-level mortality rates, present empirical evidence motivating our identification strategy, and then discuss our event-study specification.
A. Data on Health Centers and County-Level Mortality Rates
To document the rollout of CHCs from 1965 to 1974, we collected information on their establishment from two sources. Information on CHCs established by the OEO comes from the National Archives Community Action Program (NACAP) files, and information on CHCs established by the DHEW was hand-entered from annual Public Health Service (PHS) Reports.
After verifying this information against other primary sources (see Appendix A), our final database contains information on (1) the county where CHCs delivered services, which allows each federal grant to be linked to county-level mortality rates; and (2) the date that each county received its first CHC services grant (this excludes planning grants), which provides a consistent proxy for the year that each CHC began operating. There is also considerable within-state variation in CHC establishment dates. At least one CHC was established in each of 40 states; two or more were established in 28 states; three or more were established in 21 states.
We link the CHC database to county mortality rates calculated from the 1959 to 1988 Vital Statistics Multiple-Cause of Death Files (US DHHS and ICPSR 2007), which contain the universe of civilian deaths reported in the U.S. by cause, age, and county of residence of the decedent. 13 These data are aggregated to create age-specific and age-adjusted mortality rates. The age-specific mortality rate, ASMR ta , in year t is the count of deaths for age group a (50-54, 55-59,…, 75-79, 80-84, and 85+) divided by the population in age group a in year t per 100,000.
The age-adjusted mortality rate in year t is a weighted sum of age-specific mortality rates, ∑ , where s a is the 1960 national population share of age group a (among those 50 and older).
14 By holding s a fixed, changes in age-adjusted mortality rates reflect changes in the likelihood of dying rather than changes in population age structure. We also break down the AMR by six leading causes of death: 1) diseases of the heart, (2) other cardiovascular disease, 15 (3) cancer, (4) infectious disease, (5) diabetes, and (6) accidents. We include accidents, the sixth leading cause of death in 1960 for those 50 and older, as a falsification test, because accidental deaths should not be affected by the establishment of CHCs.
16

B. Empirical Specification
Our empirical strategy uses variation in when CHC programs were established to evaluate their effects on mortality. A key identifying assumption in our framework-that the timing of establishment is uncorrelated with other determinants of changes in older-adult mortality-is supported by two empirical tests. First, most 1960 socio-demographic characteristics in table 1 fail to predict when a CHC was established among those receiving one in our period of interest (appendix table B2 ).
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Significant exceptions are urban share and share of MDs per county 13 The exception is 1972, which contains a 50 percent sample. In 1981 and 1982, we use Mortality Detail files, which only contain data on the underlying cause of death, because the Multiple Cause files contain a 50 percent sample of deaths for some states. Since we only use information on the underlying cause this does not affect the comparability of our mortality measures between years. 14 Denominators for these rates were constructed by linearly interpolating population between the 1950 and 1960 censuses (Haines and ICPSR 2005) and the 1969 to 1988 Surveillance Epidemiology and End Results (SEER 2009) data. The age-groupspecific mortality rates used in this analysis are age-adjusted by 5-year groups. 15 Together, diseases of the heart and other cardiovascular disease constitute "major cardiovascular disease" (CVD). We include general arteriosclerosis in "diseases of the heart." 16 See Appendix A for details on cause of death coding and Appendix B for mortality trends by cause of death. Our age-adjusted rates for these six causes trend smoothly through two ICD-revisions (1968 and 1977) . 17 We choose these characteristics, because they have been shown to predict the timing of the implementation of other War on Poverty programs. Almond, Chay and Greenstone (forthcoming) and Hoynes and Schanzenbach (2009) report statistically significant relationships between these characteristics and the timing of Medicare certification and the initiation of the food stamps program. The power of our study relative to theirs is limited as we do not have information on the month of program population. This is not surprising: Larger, denser places had more resources and organizations that could apply for funding, and CHCs were set up in locations with physicians to staff them. To account for these potential threats to the internal validity of our analysis, we include urbangroup-by-year fixed effects and linear trends in total MDs in our primary specifications described below.
Second, we examine whether CHC program establishment is correlated with pre-program mortality rates or trends for those 50 and older. This could be the case if, for instance, proposals originated sooner in locations with higher mortality rates or the OEO prioritized locations based upon their mortality rates or early 1960s mortality trends. Figure 3 , which plots the AMR in 1965
and changes in the AMR from 1960 to 1965 against the year of CHC program establishment in funded communities, shows no evidence that either was the case (see appendix figure B2 for results by age groups). Both levels and changes in AMRs are uncorrelated with the establishment of CHCs. Overall, the lack of a systematic correlation between CHC program establishment, most socio-demographic characteristics, and mortality rates is consistent with oral histories' characterization of a "wild" funding process.
Our empirical strategy exploits variation in the timing of CHC program establishment dates within a flexible event-study framework (Jacobson et al. 1993) ,
Here is a mortality outcome in county j in year t = 1959,…,1988. 18 is a set of county fixed effects, which absorbs time-invariant differences in observable (table 1) and unobservable characteristics and allows consistent estimation of and even in the presence of differences between treated and untreated locations. is a set of urban-group-by-year fixed effects (defined as year dummies interacted with five groupings of share of a county's population in urban areas, u: 0, 0< u<25, 25≤u<50, 50≤u<75, 75≤u≤100) , which captures the differential initiation and not all of the counties in the U.S. received CHCs. For these reasons, we additionally use these demographic characteristics to construct additional control variables. 18 To ensure the parameters of the model are well estimated, we specify the dependent variable in levels rather than logs (many counties have zero deaths for a particular age or cause grouping) and limit the sample of counties to those with at least 100 residents over the age of 80 in every year. This restriction eliminates 425 counties out of 3,063 (12,840 county-year observations out of 91,980). Only two of the eliminated counties are treated (Costilla and Sauguache counties in Colorado). The mean of the excluded counties' mortality rates are similar (2,752 versus 2,757), but they have a higher standard deviation (845 versus 465) because their mortality rates are more volatile. In addition, the excluded counties sometimes have zero population in the agegroups we consider. This exclusion allows us to estimate models on a balanced set of counties. Because all models are weighted by the relevant 1960 population (to minimize the importance of noisier mortality rates in small counties), we exclude New York, Los Angeles and Chicago (these places had two million more residents in 1960 than the next largest counties To explore the sensitivity of our results, we add covariates sequentially, estimate models with county-specific, linear time trends ( ) (rather than parameterizing county trends using table 1 characteristics), and reweight the untreated counties using an estimate of the propensity of receiving a CHC to balance the characteristics of treated and untreated counties in table 1 (DiNardo, Fortin and Lemieux 1996, Heckman et al. 1998 ). Specifically, we construct propensity scores by estimating a probit with the binary dependent variable equal to 1 if a county received a CHC from 1965 to 1974 using flexible functional forms for a rich set of covariates. This yields estimates of the propensity of receiving a CHC for each county, p j = P(D j =1|Z j ). We then reweight untreated counties using the ratio, p j (1  q)/(1  p j ) q, where q is the share of counties that receive CHCs. Thus, this reweighting strategy combines information from multiple observables to give untreated counties that were ex ante most likely to have received a CHC more importance in the comparison group and weight down those that were ex ante less likely to have received a CHC. Columns 7 and 8 of table 1 show that, except for population size and location in the Northeast (which our models account for in our urban-by-year and state-by-year fixed effects), the treated county characteristics are statistically indistinguishable from those in reweighted untreated counties. As recommended by Crump et al. (2009), we also trim our estimation sample to use counties with propensity scores of at least 0.10 and no more than 0.90.
Appendix figure B4 provides full details on the construction of the propensity scores and their distribution in treated and untreated counties for the full and trimmed estimation samples.
We use a binary indicator of treatment, , equal to one if the county ever received a CHC grant, because some CHCs built upon existing resources and others required the construction of new facilities and got substantially larger start-up grants. Thus, variation in grant amounts compensated for larger infrastructure needs rather than indicating larger treatment. In our heterogeneity analysis (section III.C), we show that the effects of larger and smaller per capita grants are comparable, which supports this empirical approach. 20 The estimates characterizing CHCs' effects are the coefficients on the interaction of with 1 * , which is equal to one when the year of observation is y = 6,…,0,…,14, years from * , the date when a CHC was received in county j (y = 1 omitted). Observations more than 6 years before or more than 14 years after CHC program establishment are captured by dummies, 1 * 7 and 1 * 15 . The point estimates, , describe the evolution of mortality in eventually treated counties before CHCs began net of changes in untreated counties after adjusting for model covariates; describes the divergence in outcomes y years after the CHC was established net of changes in untreated counties after adjusting for model covariates. Because y = 1 is omitted, our point estimates describe the intention-to-treat effects of CHCs on mortality relative to the year before the CHC began (event-year 1).
This specification provides several advantages over the more standard DiD methodology.
Estimates of allow a visual and statistical evaluation of the evolution of pre-treatment unobservables in CHC communities (rather than assuming that = 0 for y<0) that may bias estimates of . Estimates of also allow an explicit test of whether the "effects" preceded the treatment even by a few years-an important falsification test. Another advantage is that the less-restrictive event-study specification describes the dynamics of the treatment effects. This is especially important since we only observe the date CHCs were established (by first grant) and not when they began operating. An abrupt shift in following the establishment of a CHC would suggest that they began operating immediately after receiving a grant whereas a break in trend would suggest a delay in CHCs becoming fully operational.
After presenting the event-study estimates, we summarize their magnitudes and joint statistical significance in a DiD specification that replaces the individual year exposure dummies with year groups,
Here is a binary variable equal to 1 if county j is treated and observed in event-year (y) group g, where g = -2, -1 indexes 7 and 6 2 and g = 0, 1, 2, and 3 index the categories 0 4, 5 9, 10 14, and 15, respectively (g = -1 is omitted).
For both the event-study and DiD specifications, tables and figures present only coefficients estimated using a balanced set of counties (only event-years 6 to +14; not all treated counties are observed for 7 or 15 . In all specifications, standard errors are corrected for heteroskedasticity and an arbitrary within-county covariance structure (Arellano 1987). Figure 4A plots weighted, event-study estimates for three models that use the AMR as the dependent variable. Model 1 includes only county fixed effects, , and urban-group-by-year fixed effects, . Model 2 adds state-by-year fixed effects, and county-level covariates,
III. EVENT-STUDY ESTIMATES OF COMMUNITY HEALTH CENTERS' EFFECT ON MORTALITY A. Results for Age-Adjusted Mortality Rates
. Model 3 adds state-by-year fixed effects and REIS covariates to model 1, but reweights the comparison group using the propensity of receiving a CHC (see appendix figure B4) . Each of the models shows that CHCs had a significant effect on mortality. The econometric model captures well the wide-spread declines in the AMR in the pre-period (urban-by-year effects presented in appendix figure B3), and estimates of are small in magnitude and statistically indistinguishable from zero. This means that the AMRs were not trending differently in eventually treated counties relative to untreated counties before the CHC program began. The establishment of a CHC, however, corresponds to a noticeable and statistically significant trend break in the AMR. In the four years after CHCs were established, the AMR fell more sharply relative to the modeled counterfactual and fell at roughly the same rate as the modeled counterfactual after event year 5.
The trend break and the magnitudes of the effects are affected little as covariates are added.
Difference-in-differences summary estimates show the robustness of these effects (table 2) .
Model 2's addition of covariates and state-by-year effects to model 1 (column (2)) reduces the magnitudes of the estimates in the pre-period and increases the absolute value of the negative estimates in years 0 to 4 by 30 percent (from 29.5, s.e. 13.7, to 40.2, s.e. 9.6) and in years 5 to 9 by 20 percent (from 58.8, s.e. 17.3, to 69.6, s.e. 14.7). Consistent with the lack of a pretreatment trend in treated counties in figure 4A , the effects are robust to the addition of over 2,600 county-specific linear trends (column (3)). These trends alter the estimates for years 0 to 4 by fewer than 2.3 deaths and, in years 5 to 9, by fewer than 9 deaths. Reweighting untreated counties to balance their observable characteristics with treated counties (column (4)) reduces the estimates slightly, but neither set of estimates (column (3) or (4)) is statistically distinguishable from model 2. 21 The robustness of the estimates in the reweighted sample is particularly helpful in narrowing the scope of omitted variables bias. Because the reweighted sample has a slightly larger number of physicians per capita and is slightly more likely to have a medical school (though neither difference is statistically different, table 1 columns (7) and (8) 
B. Translation of Intention to Treat Effects into Average Treatment Effects on the Treated
These intention-to-treat estimates (ITT) average the effect of CHCs over all residents in a county 50 and older regardless of whether they benefited from CHCs' services. What do these ITTs imply about CHCs' treatment effects on the "treated"? (By "treated" we mean those who, as a consequence of CHC establishment, obtained direct or indirect benefits they would not have otherwise received.) We use two approaches to construct the implied average treatment effect on the treated (ATET) in order to gauge the magnitude of our estimates. The first approach assumes that everyone who was elderly and poor in a county with a CHC program was "treated"-even if they did not use the CHC facility. This approach assumes that CHCs affected both patients and the community at large through externalities (eradication of infectious disease, knowledge spillovers from public health education and information, and reduced crowding of emergency departments), but that these externalities are limited to the poor. Dividing the reduction in AMR of 60 per 100,000 (table 2, average over columns (1) to (4) for years 5 to 9) by the 25 percent of the 50+ county population that was below the poverty line in 1965 yields an ATET of 240 deaths per 100,000. The second approach more narrowly assumes that only CHC patients were "treated."
Because our mortality estimates reflect the cumulative impact of CHCs on mortality, we use the 1970 SHSUE to approximate the share of 50+ residents in treated counties who had used CHCs over a five-year period. As a starting point, the SHSUE shows that 1 older by 6 to 8 percent within a decade. 22 These ATETs are also equivalent to 18 to 24 percent of the mortality gap between the poor and the non-poor for this age group, which lends credence to claims that CHCs reduced health disparities. The next section describes these mortality patterns by grant and community characteristics, age group, and cause of death to understand how CHCs achieved these effects. (4)). This is consistent with the idea that CHC programs in larger counties were more effective (see columns (5) and (6)) and historical accounts of larger grant sizes compensating for larger infrastructure needs. The comparability of effects across per-capita grant sizes also supports our empirical approach, which uses a binary indicator for treatment (rather than grant amounts).
C. Heterogeneity in Community Health Centers' Effects
Another hypothesis is that OEO-initiated CHCs were more effective, because they adhered more to the ideal of comprehensive medicine, did not implement a means test, and placed more emphasis on non-medical services (Davis and Schoen 1973: 163, Sardell 1983 ) than did DHEWfunded CHCs. Consistent with this hypothesis, the absolute effects of OEO-initiated CHCs are significantly larger at the 10-percent level than those of DHEW-initiated CHCs in every 5-year 22 Vital Statistics mortality data do not contain information on income or education. The 1966-1968 National Mortality Followback Survey (US DHHS and ICPSR 1986) sampled death certificates from 1966 to 1968 and surveyed death record informants about the decedent's household income in 1965. Together with the 1965 CPS population estimates, these data allow us to compute mortality rates by income (King et al. 2010 ). This survey shows that the AMR for those 50 and older were 50 percent higher for decedents living in a household with a total income of less than the 1965 poverty line for a family of four (<$3,000) than for those above this threshold (4,127 versus 2,769).
period after they began. The "OEO effect," however, largely reflects the types of communities these centers served, because OEO programs began earlier and were more likely to be in urban areas (table 1) . Indeed, columns (7) and (8) AMRs, the point estimates are two to seven times larger and imply a reduction of 1.5 percent and 3 percent in years 0 to 4 and 5 to 9, respectively. Although CHCs appear to have been equally successful in all census regions of the U.S., their effects are concentrated in urban areas and locations with relatively high pre-period AMRs.
Next, we examine heterogeneity in CHCs' mortality effects by age group. Figures 4B, 4C , and 4D plot weighted event-study estimates for models 1 to 3 of equation 2 using the all-cause AMR as the dependent variable for 50 to 64 year olds (B), 65 to 79 year olds (C), and 80+ year olds (D). Echoing the aggregated results, the pre-period estimates for each age group are close to zero and statistically insignificant. This means that trends in mortality rates before CHCs began
were not different in counties that eventually received programs. As with the aggregate results, the estimates exhibit a noticeable trend break following CHC program establishment. For 50 to 64 year olds, the trend break in mortality is subtle and less immediate, which reflects both the lower, shorter-term mortality risk and potentially delayed effects of primary care for this age group. In contrast, the AMR for 65 to 79 year olds fell noticeably following the establishment of CHCs. The trend break in mortality for those 80+ is also evident.
Difference-in-differences summary estimates (table 4) show the robustness of these agegroup-specific effects. Across the four models, the pre-CHC effect is small and statistically insignificant, and the post-treatment estimates are not statistically different from those in model 2. For 50 to 64 year olds (panel A, column (2)), mortality rates were 1 percent lower 0 to 4 years after CHCs began and 2.1 percent lower in years 5 to 9. Interestingly, the estimates for the 65-and-over population are even larger than those for 50 to 64 year-olds in relative terms. In years 5
Community Health Centers and Mortality -20 to 9, the AMRs were roughly 2.3 percent lower for 65 to 79 year olds (panel B, column (2)) and 1.7 percent for those 80 and older (panel C, column (2)).
Finally, table 5 shows that CHCs differentially affected deaths by different causes (these cause-specific estimates should be interpreted with caution, because the cause reporting varies over time and often with the type of care available to decedents). Importantly, CHCs' effects were concentrated among deaths related to hypertension for all age groups, but they had effects on deaths on a broader set of cause categories for 50 to 64 year olds. For these near elderly, table 5A provides evidence that CHCs reduced the AMR for all causes except accidents. Causes related to hypertension show the largest response to CHCs: heart-disease-related mortality fell by 1.3 percent (7.4 deaths per 100,000) and other CVD-related mortality fell by 2.8 percent (3.3 deaths per 100,000) within the first five years CHCs operated. In years 5 to 9, deaths in the latter category had dropped by 5.2 percent (6.1 deaths per 100,000). However, deaths from cancer, infectious disease, and diabetes also declined significantly -by 1.6 percent, 4.2 percent, and almost 7 percent, respectively, by years 5 to 9. Despite being more common than deaths from infectious disease and diabetes, deaths due to accidents, our falsification test, is the only cause that does not show an economically and statistically significant decline.
These patterns are also evident for those 65 and older (table 5, panels B and C). Heartdisease-related deaths fell by 1.7 percent in both age groups in years 5 to 9, and other CVDrelated deaths fell by a large and statistically significant 3.7 percent for the 65 to 79 year olds and 4 percent for the 80+ year olds. For both age groups, deaths due to cancer, infectious disease, and diabetes show no trend break when CHCs began. 23 It is also reassuring that CHCs have no effects on accident-related mortality.
These age-group-specific estimates translate into large impacts of CHCs on major CVD mortality for the 50-and-older population. 24 Although the difference in treated counties for both CVD categories was not (individually or jointly) statistically different from zero in the preperiod, age-adjusted deaths by those causes fell more sharply after CHCs began operating.
Model 2 implies that 5 to 9 years following program establishment, CHCs reduced the AMRs due to heart disease by 1.6 percent (25 deaths per 100,000) and other CVD-related deaths by 4 percent (17 deaths per 100,000) relative to the pre-program means. These results are consistent 23 Although the estimate for cancer for those 65 to 79 is statistically significant, so is the pre-period estimate. The corresponding event-study figure shows no trend break associated with the establishment of a CHC. 24 These estimates are reported in appendix table B4. with the RAND Health Experiment (Newhouse et al. 1993) These improvements may also reflect counseling about the warning signs of a heart attack or stroke or simple advice to improve diet or quit smoking. Thus, CHCs' primary care services complemented those available through Medicare and hospitals.
IV. AN ANALYSIS OF POTENTIAL THREATS TO INTERNAL VALIDITY
Important threats to the internal validity of the study are unobserved shocks that both reduce mortality and occur concurrently with or just after CHC program establishment. Candidates include targeted federal spending (e.g., other OEO programs which were packaged with CHC funding), correlated changes in other local medical resources, and larger effects of Medicaid in counties with CHCs.
Although oral histories provide no indication that OEO administrators intentionally bundled funded programs, the coincidence of CHC program establishment with other federal grants may have happened inadvertently or because certain (more affluent and urban, table 1) communities were more effective at writing proposals. This is an important concern, because studies show that other OEO programs also impacted mortality. 25 Although the literature does not consider the effects of OEO programs on older individuals, the programs may have benefited this group by increasing the resources available to households supporting them.
Newly compiled data on grants for other federal programs uniquely allow us to test this concern. Figure Annual Survey, figure 6 provides little evidence that this was the case. Event-study estimates using the number of hospitals and the number of hospital beds (both measured per 1,000 residents) as dependent variables show that both evolved smoothly before and after CHC programs were established. The number of hospitals per capita rose faster in locations that eventually received CHCs, but the expansions in beds were roughly keeping pace with the growth in residents-both before and after the CHC program began. In short, figure 6 provides no evidence of correlated changes in hospital capacity.
Yet another alternative explanation for CHCs' mortality effects is that counties with CHCs may have benefited disproportionately from Medicaid. Although our primary models (2, 3, and 4) account for Medicaid's state-level roll-out using state-by-year fixed effects and although the timing of Medicaid implementation is uncorrelated with CHC establishment dates, Medicaid's effects may have been larger in poorer urban areas also served by CHCs (for reasons unrelated to CHCs). 26 We evaluate this directly by including in our model a binary variable for event-years until Medicaid implementation dates interacted with county-level characteristics such as high 1960 poverty rates, high numbers of active physicians, and the presence of a medical school.
Appendix figure B6 shows that the estimated effects of CHCs from models with these controls are similar in magnitude and statistically indistinguishable from our baseline estimates.
In summary, we find no evidence that correlated local shocks in federal spending, medical resources, or state-level implementation of Medicaid compromise the internal validity of our research design or explain the mortality effects of CHCs.
V. MECHANISMS FOR COMMUNITY HEALTH CENTERS' MORTALITY EFFECTS
Thus far, we document a large, negative relationship between CHCs and older adult mortality and build an empirical case that CHCs caused to these declines. The final part of our story relates to how CHCs achieved these mortality improvements. This section assesses the contribution of three potential mechanisms linking CHCs to older-adult mortality: increases in the use and quality of primary care, the provision of anti-hypertensive drugs, and increases in the utilization of Medicare-covered services.
A. Use and Quality of Primary Care
Our investigation of the primary care mechanism relies upon the 1963 and 1970 waves of the SHSUE as described in I.A, which contain comparable questions on whether respondents had a regular source of care, 27 whether they spent any money on prescription medication, the number of doctor and hospital visits, and whether they saw a physician in the previous year. For ease of interpretation, we estimate separate models of equation 1 for three household income groups (below 100 percent, 101 to 300 percent, 301 percent and above the poverty line). Aside from income groupings or their interactions (which will not be identified in most cases because we stratify by income group), our covariates are identical to those described in equation 1 There is no evidence, however, that CHCs increased the likelihood of seeing a physician (in the previous year) for any income group (column 4). In summary, the SHSUE suggests that CHCs increased the use of primary care among the poor along the intensive (but not extensive) margin
and improved the quality and integration of that care as it was provided by a regular (or common) source. CHCs also reduced the likelihood that the poor paid for prescription drugs, which should have increased compliance with recommended treatments.
B. The Provision of Lower-Cost Hypertension Drugs
A second (and complementary) channel for CHCs' effect on older-adult mortality is the treatment of hypertension. Arguably, the most important advance in the outpatient treatment of The results of the trial show a relative reduction in the five-year, all-cause mortality risk for treated participants ages 50 to 70 of -2,160 deaths per 100,000 (HDFP 1979; table 9 ). To translate this result into the potential effect of CHCs, we multiply the HDFP treatment effect by the share of people with hypertension who used CHCs, which we assume to be the 18.5 percent utilization rate in treated communities (section III.B), and also multiply by the 26.2 percent of the population who are hypertensives (National Health Examination Survey, USDHHS and NCHS 1989a and 1989b) . If CHCs provided anti-hypertensive medication but no screening (as in the HDFP study), the trial shows that the aggregate, age-adjusted five-year mortality rate would have fallen by -105 deaths (2,160*.262*.185) per 100,000. Of course, this estimate understates CHCs' effects on hypertension-related mortality through screening, education, and other non-drug channels.
To compare this back-of-the-envelope calculation to our estimates of one-year mortality reductions, we translate our ITT estimates for years 5 to 9 (-60, average over columns (1)-(4), table 2) into a five-year mortality reduction using the mean age-adjusted mortality rate in year -1 Experiment, which found that nearly half of the reduction in blood pressure difference between those receiving free care and those with co-payment plans is attributable to the one-time initial blood pressure screening (Newhouse et al. 1993: 229, 243 The bottom line is that CHCs' mortality effects likely reflect the interactive, longer-term benefits of primary care and prescription drugs-rather than a single one of these mechanisms. 28 Because information on all per-capita medical expenditures is available from 1959 to 1988, figure 7 presents estimates from 6 forward for this outcome. In the specifications using Medicare expenditures as the dependent variable, we omit the pre-treatment coefficients from the figure because they are not based upon a balanced set of counties. We exclude counties with CHCs established before 1969 for the same reason.
VI. THE LONGER-TERM RETURNS TO PRIMARY CARE
Since 1965, the CHC experiment has been an important but understudied part of the U.S.
health care safety net-not least because the CHC program costs so much less than Medicare and
Medicaid. Even recent political support for the CHC program relates, in part, to its role as an alternative to expanding public health insurance (Mickey 2011 ). An important lesson from our analysis is that less expensive investments in the delivery of primary care may play an important role in improving the health of the poor.
The CHC program's rollout from 1965 to 1974 presents a rare opportunity to quantify the long-term effects of primary care among the underserved. Within an event-study framework, our empirical strategy exploits the disorganized grant-making process during the War on Poverty's early years. Consistent with accounts of "great administrative confusion" at the Office of Economic Opportunity (OEO) (Levine 1970) , our data show no association of CHC program establishment with a variety of pre-treatment county characteristics, with 1965 mortality rates, with changes in mortality rates from 1960 to 1965, with funding for other OEO programs, or with local expansions in hospital capacity. When CHCs began, however, is an important predictor of sharp reductions in older-adult mortality.
Our results imply that CHC induced increases in primary care led to sustained health improvements over 15 years. One decade after CHCs were established, age-adjusted all-cause mortality rates remained almost 2 percent lower than pre-program rates, owning mostly to large reductions in cardiovascular-related deaths among 65 to 79 year olds. The implied treatment effects on the treated are a 6-to 8-percent reduction in age-adjusted mortality rates among the 50-and-older poor, which amounts to an 18 to 24 percent reduction in the 1966 poor-nonpoor mortality gap for the same age group. These estimates likely understate the broader effects of increasing access to primary care, because mortality fails to capture changes in either morbidity or disability, as well as other gains to well-being. Our focus on those 50 and older also excludes benefits to other age groups.
29
Although some of CHCs' longer-term benefits accrued to individuals ineligible for Medicare, the program achieved its largest reductions in mortality among the Medicare eligible 29 Multiplying model 2 estimates in figure 4 by the relevant population in treated counties gives 107,359 life-years gained in CHCs' first ten years. We obtain the total cost of the CHC program over its first ten years by estimating the average cost of CHCs by years from the date of CHC establishment and multiplying by the 112 CHCs in our estimation sample, which yields $4.2 billion in 2010 dollars. Naively dividing the number of life-years gained by the total cost of the CHC program gives a costper-life-year of approximately $39,000 (in 2010 dollars).
without an accompanying increase in Medicare spending. Important reasons for this are that
CHCs brought physicians and health care facilities to underserved areas and provided free or substantially discounted medications-services that are unaffected by changes in public health insurance. These findings highlight the potential returns to interventions that improve the delivery of primary care. Whether the benefits of CHCs for the 50-and-older population remain this large today and whether the program also benefited younger populations remain important areas for future research. Community Health Centers and Mortality -33 Years Since Treatment
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